Previous studies showed IFNγ and IL-17A, derived from Th1 and Th17 cell respectively, played a pathology role in lupus progress in MRL/lpr mice (Schmidt et al., 2015). This evidence concerns the gene IFNG and systemic lupus erythematosus.